5-Alpha-dihydroprogesterone formation in human placenta from 5alpha-pregnan-3beta/alpha-ol-20-ones and 5-pregnan-3beta-yl-20-one sulfate
- PMID: 9449217
- DOI: 10.1016/s0960-0760(97)00058-7
5-Alpha-dihydroprogesterone formation in human placenta from 5alpha-pregnan-3beta/alpha-ol-20-ones and 5-pregnan-3beta-yl-20-one sulfate
Abstract
5Alpha-dihydroprogesterone (5alpha-DHP) is the immediate precursor of 5alpha-pregnan-3alpha-ol-20-one, a potent anxiolytic/anesthetic agent in all vertebrate animals tested, including humans. The levels of 5alpha-DHP in the plasma of pregnant women are very high; and during the third trimester of pregnancy, the blood production rate of this steroid may exceed 100 mg/24 h. 5Alpha-DHP in maternal plasma, however, cannot be accounted for totally by the metabolism of maternal plasma progesterone. This study was conducted to evaluate the possibility that 5alpha-DHP is synthesized in placenta from 5alpha-pregnan-3alpha/beta-ol-20-ones delivered to the trophoblast via the fetal umbilical blood. In incubations of placental minces with radiolabelled 5alpha-pregnan-3alpha/beta-ol-20-ones, there is extensive epimerization and the intermediate, 5alpha-DHP, is the major product. In other incubations, 5alpha-pregnan-3beta-ol-20-one-sulfate was hydrolysed and the liberated 5alpha-pregnan-3beta-ol-20-one was converted to 5alpha-DHP by homogenates of placental tissue, but 5alpha-pregnan-3beta-ol-20-one-sulfate was not. The oxidation of 5alpha-pregnan-3alpha/beta-ol-20-ones was concentrated in microsome-enriched preparations of placental tissue and the apparent Kms for 5alpha-pregnan-3alpha-ol-20-one and 5alpha-pregnan-3beta-ol-20-one were 3.6 microM and 78 nM, respectively. The Vmaxs for 5alpha-DHP formation from 5alpha-pregnan-3alpha-ol-20-one and 5alpha-pregnan-3beta-ol-20-one were, respectively, 336 pmol/min/mg protein and 9.7 nmol/min/mg protein. These oxidation reactions were supported by both NAD+ and NADP+. We suggest that progesterone, which enters the umbilical circulation from its site of synthesis in the syncytiotrophoblast, is metabolized in the fetus to 5alpha-pregnan-3alpha/beta-ol-ones and to 5alpha-pregnan-3alpha/beta-yl-20-one sulfates. These metabolites of progesterone, 5alpha-pregnan-3alpha/beta-ol-20-one and 5alpha-pregnan-3beta-yl-20-one sulfate, formed in the fetus, serve as plasma-borne substrates for trophoblast formation of 5alpha-DHP. Because of the hemochorioendothelial nature of human placentation, 5alpha-DHP secreted from the trophoblast will preferentially enter the maternal compartment, thus constituting a maternal plasma progesterone-independent source of 5alpha-DHP.
Similar articles
-
Brexanolone.2023 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 31038852 Free Books & Documents. Review.
-
3alpha-hydroxy-5alpha-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors.Neuroscience. 2006;138(3):1007-14. doi: 10.1016/j.neuroscience.2005.06.015. Epub 2005 Dec 1. Neuroscience. 2006. PMID: 16324790 Free PMC article. Review.
-
Human saturated steroid 6alpha-hydroxylase.J Clin Endocrinol Metab. 1997 May;82(5):1338-44. doi: 10.1210/jcem.82.5.3908. J Clin Endocrinol Metab. 1997. PMID: 9141513
-
Metabolism of 5 alpha-dihydroprogesterone in women and men: 3 beta- and 3 alpha-,6 alpha-dihydroxy-5 alpha-pregnan-20-ones are major urinary metabolites.J Clin Endocrinol Metab. 1996 Oct;81(10):3644-9. doi: 10.1210/jcem.81.10.8855816. J Clin Endocrinol Metab. 1996. PMID: 8855816
-
Uptake of (3H)progesterone and (3H)5alpha-dihydroprogesterone by rat tissues in vivo and analysis of accumulated radioactivity: accumulation of 5alpha-dihydroprogesterone by pituitary and hypothalamic tissues.Endocrinology. 1976 Jan;98(1):164-75. doi: 10.1210/endo-98-1-164. Endocrinology. 1976. PMID: 765114
Cited by
-
Allopregnanolone: Regenerative therapeutic to restore neurological health.Neurobiol Stress. 2022 Nov 5;21:100502. doi: 10.1016/j.ynstr.2022.100502. eCollection 2022 Nov. Neurobiol Stress. 2022. PMID: 36532370 Free PMC article.
-
Steroid hormone bioavailability is controlled by the lymphatic system.Sci Rep. 2021 May 6;11(1):9666. doi: 10.1038/s41598-021-88508-w. Sci Rep. 2021. PMID: 33958648 Free PMC article.
-
Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial.Alzheimers Dement (N Y). 2020 Dec 16;6(1):e12107. doi: 10.1002/trc2.12107. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 33344752 Free PMC article.
-
Knowledge Gaps and Emerging Research Areas in Intrauterine Growth Restriction-Associated Brain Injury.Front Endocrinol (Lausanne). 2019 Mar 29;10:188. doi: 10.3389/fendo.2019.00188. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30984110 Free PMC article. Review.
-
Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.Front Endocrinol (Lausanne). 2012 Jan 12;2:117. doi: 10.3389/fendo.2011.00117. eCollection 2011. Front Endocrinol (Lausanne). 2012. PMID: 22654847 Free PMC article.